These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 10665286)
1. [Parameters of blood proteinase inhibitor balance and hyperlipoproteinemia in patients with proliferative diabetic retinopathy with vitreous hemorrhage]. Chesnokova NB; Kuznetsova TP; Davydova GA; Grigor'ev AV Vestn Oftalmol; 1999; 115(6):29-32. PubMed ID: 10665286 [TBL] [Abstract][Full Text] [Related]
2. [Hyperlipoproteinemias and proteinase inhibitor balance in patients with proliferative diabetic retinopathy with solid exudates in retina]. Chesnokova NB; Kuznetsova TP; Davydova GA; Grigor'ev AV Vestn Oftalmol; 1999; 115(1):14-6. PubMed ID: 10207312 [TBL] [Abstract][Full Text] [Related]
3. [Contribution of selected cellular adhesion molecules and proinflammatory cytokines in the pathogenesis of proliferative diabetic retinopathy]. Adamiec J; Oficjalska-Młyńczak J Przegl Lek; 2007; 64(6):389-92. PubMed ID: 18159844 [TBL] [Abstract][Full Text] [Related]
4. [Proteinases inhibitors in sera of diabetic patients with non-proliferative retinopathy]. Skopiński P; Duda-Król B; Lipińska A; Sommer E; Borowska A; Filewska M; Szaflik J; Skopińska-Rózewska E; Struzik E Klin Oczna; 2004; 106(3 Suppl):424-6. PubMed ID: 15636223 [TBL] [Abstract][Full Text] [Related]
5. High vitreous concentration of vascular endothelial growth factor in diabetic patients with proliferative retinopathy using statins. Liinamaa MJ; Savolainen MJ Ann Med; 2008; 40(3):209-14. PubMed ID: 18382886 [TBL] [Abstract][Full Text] [Related]
6. Coagulation factors of contact phase of haemostasis are normal in well-controlled type-I diabetic patients despite presence of diabetic retinopathy. Watzke H; Schernthaner G; Schnack C; Schwarz HP; Prskavec F; Freyler H Diabetes Res; 1988 Apr; 7(4):197-200. PubMed ID: 3402169 [TBL] [Abstract][Full Text] [Related]
7. TNF-alpha is an independent serum marker for proliferative retinopathy in type 1 diabetic patients. Gustavsson C; Agardh E; Bengtsson B; Agardh CD J Diabetes Complications; 2008; 22(5):309-16. PubMed ID: 18413212 [TBL] [Abstract][Full Text] [Related]
8. Does cardiovascular therapy affect the onset and recurrence of preretinal and vitreous haemorrhage in diabetic eye disease? Banerjee S; Denniston AK; Gibson JM; Dodson PM Eye (Lond); 2004 Aug; 18(8):821-5. PubMed ID: 14976546 [TBL] [Abstract][Full Text] [Related]
9. [Activities of trypsin-like serine proteases and their inhibitors in blood and subretinal fluid of patients with different stages of proliferative vitreoretinopathy in rhegmatogenous retinal detachment]. Katsnel'son LA; Chesnokova NB; Antelava ND Vestn Oftalmol; 2000; 116(1):24-6. PubMed ID: 10741259 [TBL] [Abstract][Full Text] [Related]
10. Differential expression of vitreous proteins in proliferative diabetic retinopathy. Kim SJ; Kim S; Park J; Lee HK; Park KS; Yu HG; Kim Y Curr Eye Res; 2006 Mar; 31(3):231-40. PubMed ID: 16531280 [TBL] [Abstract][Full Text] [Related]
11. Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy. Hogeboom van Buggenum IM; Polak BC; Reichert-Thoen JW; de Vries-Knoppert WA; van Hinsbergh VW; Tangelder GJ Diabetologia; 2002 Feb; 45(2):203-9. PubMed ID: 11935151 [TBL] [Abstract][Full Text] [Related]
12. Intravitreal long-acting gas in the prevention of early postoperative vitreous hemorrhage in diabetic vitrectomy. Yang CM; Yeh PT; Yang CH Ophthalmology; 2007 Apr; 114(4):710-5. PubMed ID: 17275908 [TBL] [Abstract][Full Text] [Related]
13. Elevated circulating levels of matrix metalloproteinase-9 in type 1 diabetic patients with and without retinopathy. Jacqueminet S; Ben Abdesselam O; Chapman MJ; Nicolay N; Foglietti MJ; Grimaldi A; Beaudeux JL Clin Chim Acta; 2006 May; 367(1-2):103-7. PubMed ID: 16426593 [TBL] [Abstract][Full Text] [Related]
14. Plasma levels of adrenomedullin, a vasoactive peptide, in type 2 diabetic patients with and without retinopathy. Caliumi C; Balducci S; Petramala L; Cotesta D; Zinnamosca L; Cianci R; Di Donato D; Vingolo EM; Fallucca F; Letizia C Minerva Endocrinol; 2007 Jun; 32(2):73-8. PubMed ID: 17557032 [TBL] [Abstract][Full Text] [Related]
15. [Clinical efficacy of eiconol in patients with diabetic retinopathy]. Sorokin EL; Smoliakova GP; Bachaldin IL Vestn Oftalmol; 1997; 113(4):37-9. PubMed ID: 9381643 [TBL] [Abstract][Full Text] [Related]
16. Effect of retinal laser photocoagulation on the activity of metalloproteinases and the alpha(2)-macroglobulin proteolytic state in the vitreous of eyes with proliferative diabetic retinopathy. Sánchez MC; Luna JD; Barcelona PF; Gramajo AL; Juarez PC; Riera CM; Chiabrando GA Exp Eye Res; 2007 Nov; 85(5):644-50. PubMed ID: 17826767 [TBL] [Abstract][Full Text] [Related]
18. [Cryotherapy of vitreous hemorrhage in diabetic retinopathy]. Lenkiewicz E; Stankiewicz A; Ejchartowa I; Zywalewski B Klin Oczna; 1989; 91(7-9):195-6. PubMed ID: 2638443 [TBL] [Abstract][Full Text] [Related]
19. Blood antioxidant parameters in patients with diabetic retinopathy. Siemianowicz K; Gminski J; Telega A; Wójcik A; Posielezna B; Grabowska-Bochenek R; Francuz T Int J Mol Med; 2004 Sep; 14(3):433-7. PubMed ID: 15289896 [TBL] [Abstract][Full Text] [Related]
20. [Character of changes in indicators of proteinase and proteinase inhibitor activity in gastroenterological pathology in children]. Dovgun OB; Tebloeva LT; Shumeĭko NK; Rudenskaia GN Vopr Med Khim; 1998; 44(3):282-7. PubMed ID: 9703629 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]